Syndax Pharma (SNDX)

Trade SNDX now with
9/27/2021 6:02:33 AM Syndax Pharma, Incyte Enters Exclusive Worldwide Collaboration And License Agreement To Develop Axatilimab
9/15/2021 4:03:39 PM Syndax Appoints Martin Huber To Its Board Of Directors
6/28/2021 7:10:41 AM Syndax : SNDX-5613 Granted FDA Fast Track Designation For Treatment Of Relapsed/Refractory Acute Leukemias
4/15/2021 7:17:27 AM Syndax Pharma To Provide Updated Data From Phase 1 Portion Of AUGMENT-101 Trial Of SNDX-5613 On Apr 20
3/31/2021 7:08:06 AM Syndax: FDA Grants Orphan Drug Designation To Axatilimab For Patients With Chronic Graft Versus Host Disease
12/9/2020 6:32:14 AM Syndax Reports Pricing Of Public Offering Of 5.43 Mln Common Shares At $23/Shr
7/7/2020 7:08:47 AM Syndax Pharma Appoints Daphne Karydas As CFOr, Effective July 13
5/22/2020 10:21:35 AM Stock Alert: Synadax Down 18%
4/30/2020 7:55:08 AM Syndax Pharma Says Prices Underwritten Public Offering Of 5.55 Mln Shares At $18/shr
1/31/2020 7:08:19 AM Syndax Announces $35 Mln Offering Of Common Stock And Enters Term Sheet For Loan With Hercules Capital For $30 Mln